# UDR, Inc.: financial statements, quarterly

UDR · NYSE · CIK 74208 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/udr.md) · [Financials](/companies/udr/financials.md) · [Filings](/companies/udr/filings.md) · [Insiders](/companies/udr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/udr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.5](/filings/0000074208-24-000060.md) | [1.8](/filings/0000074208-24-000081.md) | [2.4 d](/filings/0000074208-26-000013.md) | [2.0](/filings/0000074208-25-000036.md) | [2.0](/filings/0000074208-25-000051.md) | [2.1](/filings/0000074208-25-000072.md) | [2.3 d](/filings/0000074208-26-000013.md) | [2.1](/filings/0000074208-26-000049.md) | [2.4](/filings/0000074208-25-000051.md) | [2.6](/filings/0000074208-25-000072.md) | [4.3 d](/filings/0000074208-26-000013.md) | [2.5](/filings/0000074208-26-000049.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | [8.3](/filings/0000074208-25-000036.md) | [9.0](/filings/0000074208-25-000051.md) | [9.6](/filings/0000074208-25-000072.md) | not reported | [9.5](/filings/0000074208-25-000036.md) | [10.0](/filings/0000074208-25-000051.md) | [10.5](/filings/0000074208-25-000072.md) | not reported | not reported |
| Operating income | $m | [397](/filings/0000074208-24-000060.md) | [78.1](/filings/0000074208-24-000081.md) | [94.2 d](/filings/0000074208-26-000013.md) | [79.8](/filings/0000074208-25-000036.md) | [68.7](/filings/0000074208-25-000051.md) | [69.9](/filings/0000074208-25-000072.md) | [66.3 d](/filings/0000074208-26-000013.md) | [122](/filings/0000074208-26-000049.md) | [77.4](/filings/0000074208-25-000051.md) | [76.4](/filings/0000074208-25-000072.md) | [278 d](/filings/0000074208-26-000013.md) | [230](/filings/0000074208-26-000049.md) |
| Interest expense | $m | [45.1](/filings/0000074208-23-000056.md) | [44.7](/filings/0000074208-23-000066.md) | [47.3 d](/filings/0000074208-24-000011.md) | [48.1](/filings/0000074208-24-000039.md) | [47.8](/filings/0000074208-25-000051.md) | [50.2](/filings/0000074208-25-000072.md) | [49.6 d](/filings/0000074208-26-000013.md) | [47.7](/filings/0000074208-26-000049.md) | [48.7](/filings/0000074208-25-000051.md) | [50.6](/filings/0000074208-25-000072.md) | [49.7 d](/filings/0000074208-26-000013.md) | [48.6](/filings/0000074208-26-000049.md) |
| Income tax | $m | [1.4](/filings/0000074208-24-000060.md) | [0.4](/filings/0000074208-24-000081.md) | [0.1 d](/filings/0000074208-26-000013.md) | [0.3](/filings/0000074208-25-000036.md) | [0.4](/filings/0000074208-25-000051.md) | [(0.2)](/filings/0000074208-25-000072.md) | [0.3 d](/filings/0000074208-26-000013.md) | [0.2](/filings/0000074208-26-000049.md) | [0.3](/filings/0000074208-25-000051.md) | [0.4](/filings/0000074208-25-000072.md) | [0.0 d](/filings/0000074208-26-000013.md) | [0.5](/filings/0000074208-26-000049.md) |
| Net income | $m | [348](/filings/0000074208-24-000060.md) | [32.9](/filings/0000074208-24-000081.md) | [33.0 d](/filings/0000074208-26-000013.md) | [43.1](/filings/0000074208-25-000036.md) | [28.9](/filings/0000074208-25-000051.md) | [22.6](/filings/0000074208-25-000072.md) | [(5.0) d](/filings/0000074208-26-000013.md) | [76.7](/filings/0000074208-26-000049.md) | [37.7](/filings/0000074208-25-000051.md) | [40.4](/filings/0000074208-25-000072.md) | [223 d](/filings/0000074208-26-000013.md) | [190](/filings/0000074208-26-000049.md) |
| Diluted EPS | $ per share | [1.05](/filings/0000074208-24-000060.md) | [0.10](/filings/0000074208-24-000081.md) | not reported | [0.13](/filings/0000074208-25-000036.md) | [0.08](/filings/0000074208-25-000051.md) | [0.06](/filings/0000074208-25-000072.md) | not reported | [0.23](/filings/0000074208-26-000049.md) | [0.11](/filings/0000074208-25-000051.md) | [0.12](/filings/0000074208-25-000072.md) | not reported | [0.57](/filings/0000074208-26-000049.md) |
| Basic EPS | $ per share | [1.05](/filings/0000074208-24-000060.md) | [0.10](/filings/0000074208-24-000081.md) | not reported | [0.13](/filings/0000074208-25-000036.md) | [0.08](/filings/0000074208-25-000051.md) | [0.06](/filings/0000074208-25-000072.md) | not reported | [0.23](/filings/0000074208-26-000049.md) | [0.11](/filings/0000074208-25-000051.md) | [0.12](/filings/0000074208-25-000072.md) | not reported | [0.58](/filings/0000074208-26-000049.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0000074208-24-000060.md) | [0.0](/filings/0000074208-24-000081.md) | [0.0](/filings/0000074208-26-000013.md) | [0.0](/filings/0000074208-25-000036.md) | [0.0](/filings/0000074208-25-000051.md) | [0.0](/filings/0000074208-25-000072.md) | [0.0](/filings/0000074208-26-000049.md) | [0.0](/filings/0000074208-26-000049.md) | [0.0](/filings/0000074208-25-000051.md) | [0.0](/filings/0000074208-25-000072.md) | [0.0](/filings/0000074208-26-000049.md) | [0.0](/filings/0000074208-26-000049.md) |
| Total assets | $bn | [11.1](/filings/0000074208-23-000056.md) | [11.4](/filings/0000074208-23-000066.md) | [11.4](/filings/0000074208-25-000010.md) | [11.2](/filings/0000074208-24-000039.md) | [11.1](/filings/0000074208-24-000060.md) | [11.1](/filings/0000074208-24-000081.md) | [10.9](/filings/0000074208-26-000013.md) | [10.7](/filings/0000074208-25-000036.md) | [10.6](/filings/0000074208-25-000051.md) | [10.6](/filings/0000074208-25-000072.md) | [10.6](/filings/0000074208-26-000049.md) | [10.3](/filings/0000074208-26-000049.md) |
| Total liabilities | $bn | [6.0](/filings/0000074208-23-000056.md) | [6.4](/filings/0000074208-23-000066.md) | [6.4](/filings/0000074208-25-000010.md) | [6.3](/filings/0000074208-24-000039.md) | [6.4](/filings/0000074208-24-000060.md) | [6.5](/filings/0000074208-24-000081.md) | [6.4](/filings/0000074208-26-000013.md) | [6.4](/filings/0000074208-25-000036.md) | [6.4](/filings/0000074208-25-000051.md) | [6.5](/filings/0000074208-25-000072.md) | [6.5](/filings/0000074208-26-000049.md) | [6.2](/filings/0000074208-26-000049.md) |
| Long-term debt | $bn | [5.4](/filings/0000074208-23-000056.md) | [5.8](/filings/0000074208-23-000066.md) | [5.8](/filings/0000074208-25-000010.md) | [5.8](/filings/0000074208-24-000039.md) | [5.8](/filings/0000074208-24-000060.md) | [5.9](/filings/0000074208-24-000081.md) | [5.8](/filings/0000074208-26-000013.md) | [5.8](/filings/0000074208-25-000036.md) | [5.8](/filings/0000074208-25-000051.md) | [5.8](/filings/0000074208-25-000072.md) | [5.8](/filings/0000074208-26-000049.md) | [5.7](/filings/0000074208-26-000049.md) |
| Shareholders' equity | $bn | [4.1](/filings/0000074208-23-000056.md) | [4.2](/filings/0000074208-23-000066.md) | [4.0](/filings/0000074208-25-000010.md) | [3.9](/filings/0000074208-24-000039.md) | [3.7](/filings/0000074208-24-000060.md) | [3.5](/filings/0000074208-24-000081.md) | [3.4](/filings/0000074208-26-000013.md) | [3.3](/filings/0000074208-25-000036.md) | [3.3](/filings/0000074208-25-000051.md) | [3.3](/filings/0000074208-25-000072.md) | [3.3](/filings/0000074208-26-000049.md) | [3.3](/filings/0000074208-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [242 d](/filings/0000074208-24-000060.md) | [204 d](/filings/0000074208-24-000081.md) | [219 d](/filings/0000074208-26-000013.md) | [168](/filings/0000074208-25-000036.md) | [238 d](/filings/0000074208-25-000051.md) | [230 d](/filings/0000074208-25-000072.md) | [241 d](/filings/0000074208-26-000013.md) | [156](/filings/0000074208-26-000049.md) | [250 d](/filings/0000074208-25-000051.md) | [235 d](/filings/0000074208-25-000072.md) | [261 d](/filings/0000074208-26-000013.md) | [129](/filings/0000074208-26-000049.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [138 d](/filings/0000074208-24-000060.md) | [138 d](/filings/0000074208-24-000081.md) | [138 d](/filings/0000074208-26-000013.md) | [138](/filings/0000074208-25-000036.md) | [140 d](/filings/0000074208-25-000051.md) | [140 d](/filings/0000074208-25-000072.md) | [140 d](/filings/0000074208-26-000013.md) | [141](/filings/0000074208-26-000049.md) | [142 d](/filings/0000074208-25-000051.md) | [142 d](/filings/0000074208-25-000072.md) | [142 d](/filings/0000074208-26-000013.md) | [141](/filings/0000074208-26-000049.md) |
| Share repurchases | $m | not reported | [25.0](/filings/0000074208-23-000066.md) | [0.0 d](/filings/0000074208-26-000013.md) | not reported | not reported | not reported | not reported | not reported | not reported | [25.0](/filings/0000074208-25-000072.md) | [92.8 d](/filings/0000074208-26-000013.md) | [100](/filings/0000074208-26-000049.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [320](/filings/0000074208-23-000056.md) | [326](/filings/0000074208-23-000066.md) | [329](/filings/0000074208-24-000039.md) | [332](/filings/0000074208-24-000060.md) | [329](/filings/0000074208-24-000081.md) | [329](/filings/0000074208-25-000036.md) | [330](/filings/0000074208-25-000051.md) | [331](/filings/0000074208-25-000072.md) | [332](/filings/0000074208-26-000049.md) | [332](/filings/0000074208-25-000051.md) | [331](/filings/0000074208-25-000072.md) | [330](/filings/0000074208-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 324,915,653 at 2026-04-27, from the cover of the [10-Q filed 2026-04-30](/filings/0000074208-26-000049.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.